U.S. Surgeon General’s Advisory: Marijuana Use and the Developing Brain
The U.S. Surgeon General offers a statement on marijuana us and the developing brain:
“I, Surgeon General VADM Jerome Adams, am emphasizing the importance of protecting our Nation from the health risks of marijuana use in adolescence and during pregnancy. Recent increases in access to marijuana and in its potency, along with misperceptions of safety of marijuana endanger our most precious resource, our nation’s youth.“
KNOW THE RISKS. TAKE ACTION. PROTECT OUR FUTURE.
Click HERE to read the full article
December is Drunk/Drugged Driving Prevention Month
The National Highway Traffic Safety Administration (NHTSA), within the U.S. Department of Transportation, with the White House’s Office of National Drug Control Policy (ONDCP), and the U.S. Department of Health and Human Service’s Substance Abuse and Mental Health Services Administration remind you to celebrate safely this holiday season.
You can find communication campaign resources from Traffic Safety Marketing:
E-cigarette Ads Associated with Cigarette Smoking Initiation Among Youth
A scientific study finds that receptivity to e-cigarette advertising increases the likelihood of trying conventional cigarettes one year later. The study found that young people ages 12-21 who had never previously smoked, but were receptive to e-cigarette advertising, were 60 percent more likely to try smoking cigarettes one year later, compared to teens who were not receptive to the ads. Study participants were considered receptive to an advertisement if they reported liking or recognizing images from the ad.
Click HERE for more information
New Treatment Guidance for Pregnant Mothers with Opioid Use Disorder
The Substance Abuse and Mental Health Services Administration (SAMHSA) released new Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants.
SAMHSA’s Clinical Guidance comes at a time of great need for effective opioid use disorder (OUD) treatment. In 2016, over 20,000 pregnant women reported using heroin or misusing pain relievers in the past month. Newborn babies of mothers who used opioids while pregnant are at risk of neonatal abstinence syndrome–a group of physical and neurobehavioral signs of withdrawal.
The guidance, which consists of 16 fact sheets on prenatal, infant, and maternal postnatal care, contains four elements: clinical scenario; clinical action steps; supporting evidence and clinical considerations; and web resources. Detailed, evidence-based treatment options for pregnant women with OUD including pharmacotherapy with methadone, buprenorphine, and buprenorphine/naloxone are provided.
Click HERE for more information